Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
Sharma joined the Morepen Lab in 2004
This agreement paves the way for the introduction of YESAFILI into the Canadian market
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
The product will be launched in March 2024
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
Cipla completes transfer of Generics Business Undertaking
Subscribe To Our Newsletter & Stay Updated
